Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Stockholder's Equity Statement

v3.21.1
Consolidated Statement of Stockholder's Equity Statement - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Accumulated Deficit [Member]
Shares issued, beginning of period (in shares) at Dec. 31, 2019   71,931      
Total stockholders' equity, beginning of period at Dec. 31, 2019 $ 414,920 $ 7 $ 529,596 $ (887) $ (113,796)
Common Stock Issued Pursuant To Equity Awards Net Shares   414      
Common stock issued pursuant to equity awards, net, value 2,612   2,612    
Repurchase of common stock 0        
APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6,827   6,827    
Other Comprehensive Income (Loss), Net of Tax (733)     (733)  
Net income (loss) (15,469)       (15,469)
Total stockholders' equity, end of period at Mar. 31, 2020 408,157 $ 7 539,035 (1,620) (129,265)
Shares issued, end of period (in shares) at Mar. 31, 2020   72,345      
Shares issued, beginning of period (in shares) at Dec. 31, 2020   74,536      
Total stockholders' equity, beginning of period at Dec. 31, 2020 391,117 $ 7 602,064 1,435 (212,389)
Common Stock Issued Pursuant To Equity Awards Net Shares   917      
Stock Issued During Period, Value, New Issues   $ 1      
Common stock issued pursuant to equity awards, net, value $ 16,566   16,565    
Stock Repurchased During Period, Shares (75)        
Repurchase of common stock $ (2,673)   2,673    
APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12,955   12,955    
Other Comprehensive Income (Loss), Net of Tax (989)     (989)  
Net income (loss) 3,802       3,802
Total stockholders' equity, end of period at Mar. 31, 2021 $ 420,778 $ 8 $ 628,911 $ 446 $ (208,587)
Shares issued, end of period (in shares) at Mar. 31, 2021   75,378